Part-Time

District Support Pharmacist

Posted on 7/2/2026

Deadline 9/1/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$60 - $73/hr

Company Historically Provides H1B Sponsorship

Tennessee, USA

In Person

Willing to travel within the district to cover stores; in-store attendance required including nights/weekends.

Category
Medical, Clinical & Veterinary
Required Skills
Inventory Management

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Active Pharmacist License in the state where the Store is located
  • Active National Provider Identifier (NPI)
  • Not on the DEA Excluded Parties list
Responsibilities
  • Living our purpose by helping to manage and improve patient health through safe and appropriate dispensing, counseling, and immunizing practices
  • Traveling the district to fill pharmacist shifts as scheduled by the District Performance Coordinator (DPC); overseeing the pharmacy and serving as the Pharmacy Manager’s proxy during bench shifts without overlap
  • Supporting safe and accurate prescription fulfillment by following—and directing the pharmacy team to follow—pharmacy workflow procedures and utilizing the safety guardrails at every workstation
  • Assumes Pharmacy Manager’s day-to-day duties when serving as the only or the primary pharmacist-on-duty
  • Contributing to positive patient experiences by showing empathy and genuine care and coaching the pharmacy team to do the same: demonstrating compassionate care, collaborating with the patient’s total healthcare team, and proactively resolving insurance and/or medication issues
  • Proactively offering and delivering immunizations to keep patients healthy; engaging and supporting Pharmacy Technicians to learn to immunize
  • Supporting the effective management of pharmacy inventory in all pharmacies worked by following—and guiding the pharmacy team to follow—all inventory best practices, with a special focus on protecting cold chain products for our patients and our business
  • Remaining flexible for both scheduling and business needs, while contributing to a safe, inclusive, and engaging team dynamic
  • Maintaining relevant clinical and technical skills for the job as the industry evolves (including but not limited to company-required trainings and CMEs); actively seeking opportunities to expand knowledge to better support patients
  • Supporting access to care and helping to improve patient outcomes through pharmacist delivered clinical care such as testing and prescribing services (e.g., COVID/Flu, Hormonal Contraception, etc.) where permissible; empowers the pharmacy team to provide holistic care at every step in the patient care journey
  • Understanding and complying with all relevant federal and state laws, regulations, professional standards, and ethical principles; complying with CVS Health policies and procedures to help support patient safety and complying with controlled substance dispensing and recordkeeping, to protect patient privacy and security, and to maintain a safe and inclusive workplace for our colleagues
  • Any additional tasks as directed by Supervisor or Manager
Desired Qualifications
  • 1-2 years of related work experience in a pharmacy, retail, medical, or customer service setting

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 Q2 revenue hit $106.1 billion, and adjusted EPS reached $2.58.
  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow to $11.5 billion.
  • July 14, 2026 FTC settlement removed PBM litigation over rebates and network contracting.

What critics are saying

  • 340B lawsuits from Mount Sinai, Michigan, and Kansas seek hundreds of millions from CVS.
  • Pharmacy revenue depends on Rite Aid gains normalizing after 2025 bankruptcy acquisitions.
  • CVS carries $175 billion liabilities; PBM regulation could break the integration thesis by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies into one consumer funnel.
  • August 5, 2026 Eli Lilly deal puts Zepbound pricing inside CVS Health app.
  • CVS's $20 billion AI program unifies claims, pharmacy, and care workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.

PR Newswire
Aug 5th, 2026
CVS Health posts $106.1B Q2 revenue, raises full-year earnings guidance to $7.90-$8.10

CVS Health reported second quarter 2026 revenues of $106.1 billion, up 7.3% year-over-year. The company posted GAAP diluted earnings per share of $2.31 and adjusted EPS of $2.58, compared to $0.80 and $1.81 respectively in the prior year. The company raised its full-year 2026 guidance, increasing GAAP diluted EPS guidance to $6.84-$7.04 from $6.24-$6.44 and adjusted EPS guidance to $7.90-$8.10 from $7.30-$7.50. Cash flow from operations guidance was raised to at least $11.5 billion from at least $9.5 billion. CVS Health generated $10.6 billion in year-to-date cash flow from operations. The improved performance was primarily driven by the Health Care Benefits segment, reflecting continued execution on its margin recovery plan. The company operates approximately 9,000 retail pharmacy locations and serves around 87 million plan members through its pharmacy benefits manager.

INACTIVE